SEC Form 4 · accession 0001171843-16-010533
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Arthur Eldridge
Officer — Sr VP, CFO, Treasurer, Sec.
Period of report
Jun 6, 2016
Accepted (ET)
Jun 7, 2016 · 7:49 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2016 | P | 2,750 | $5.78 | A | 2,750 | D | |
| Common StockF2 | Jun 6, 2016 | P | 425 | $5.76 | A | 425 | I | As custodian for child's UTMA account |
| Common StockF2 | Jun 6, 2016 | P | 425 | $5.776 | A | 425 | I | As custodian for child's UTMA account |
| Common StockF2 | Jun 6, 2016 | P | 400 | $5.78 | A | 400 | I | As custodian for child's UTMA account |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchase price of $5.78 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $5.78 to $5.79. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2These securities were purchased by the reporting person as custodian for three minor children under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.